TECH vs ZTS Stock Comparison

Compare TECH and ZTS across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.

Market data as of Sep 6, 2026 market close· AIQ score gap 8 points
TECH
Healthcare
vs
ZTS
Healthcare
TECH
Bio-Techne Corporation
Price
$72.43
Day move
-0.03%
AIQ Score
56/100
Best edge
Risk Resilience
Sector
Healthcare
ZTS
Zoetis Inc.
Leads
Price
$75.81
Day move
-0.63%
AIQ Score
64/100
Best edge
Value
Sector
Healthcare

What is the main difference between TECH and ZTS?

ZTS leads the current stock comparison as Zoetis Inc., with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Bio-Techne Corporation vs Zoetis Inc.

Data as of Sep 6, 2026· market close· Healthcare· Coverage 66/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 5/10

ZTS leads

ZTS leads by 8 AIQ points, primarily on Value and Quality, having only recently taken the lead back from TECH.

Fragile: 4 of 6 evidence groups support ZTS, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Reversed
TECH

Bio-Techne Corporation

AIQ Score
56/100
AIQ Edge Score
7/10
ZTS

Zoetis Inc.

Leads
AIQ Score
64/100
AIQ Edge Score
9/10

The Algovestiq AIQ Score currently favors ZTS over TECH, 64 versus 56 as of Sep 6, 2026. ZTS's advantage is driven primarily by stronger value and quality, while TECH holds the stronger risk resilience profile. ZTS also shows the weaker technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor ZTS today, and the comparison is rated Fragile on stability: the lead has already changed hands inside the comparison window. ZTS lead: Reversed — TECH led by 2 AIQ points 30 sessions ago; ZTS now leads by 8.

Compare Bio-Techne Corporation and Zoetis Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Performance over time

Price-return comparison using available daily close history.

TECH
-42.9%
ZTS
-63.8%

Total return comparison

Growth of $10,000

TECH $5,706 · ZTS $3,622

Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.

Compare TECH and ZTS against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

TECH advantage
0
ZTS advantage
  • Value30%26 vs 62
    ZTS +36
  • Risk Resilience15%89 vs 55
    TECH +34
  • Quality30%66 vs 70
    ZTS +4
  • Momentum25%62 vs 63
    Even

4 of 6 evidence groups favor ZTS. ZTS’s edge is concentrated in value and quality; TECH keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-09-05, compared against the prior scored session 2026-09-04.

TECH0 AIQ

No factor moved materially.

No new signals fired.

ZTS0 AIQ

No factor moved materially.

No new signals fired.

ZTS's lead was unchanged in the latest snapshot.

Deeper signal detail for each name lives on its own signals page — TECH and ZTS both carry a full feed there.

The central trade-off

ZTS (Zoetis Inc.): the stronger current systematic profile, led by value and quality.

TECH (Bio-Techne Corporation): the counter-case, on risk resilience, technicals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

ZTS

ZTS on the overall AIQ Score, which weights Quality and Value at 30% each.

Growth

ZTS

ZTS on combined revenue and EPS growth.

Value

ZTS

ZTS on the peer-relative Value factor, by 36 points.

Momentum

Even

The two are level on Momentum.

Lower downside

TECH

TECH on Risk Resilience, by 34 points.

Analyst upside

ZTS

ZTS on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureTECHZTSNote
Implied upside to target-11.5%+27%ZTS has more room
Target dispersion+37.4%+51.9%Lower is tighter analyst agreement
ConsensusHoldBuyContext, not a primary driver
Analysts covering96Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor ZTS. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreZTS56 vs 64
FundamentalsZTSrevenue growth 3.1% vs 9.1%; EPS growth 6.1% vs 16.2%; TTM ROE 8.9% vs 69.3%; gross margin 65.8% vs 70.9%; operating margin 20.7% vs 37%
ValuationZTSValue 26 vs 62
TechnicalsTECHPrice vs 50-day 0.8% vs 0.3%; vs 200-day 18.7% vs -26.4%
Risk ResilienceTECHRisk Resilience 89 vs 55
Analyst expectationsZTSTarget upside -11.5% vs 27%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of TECH and ZTS and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 8 points.
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ZTS.

How the comparison changed

120 daily snapshots · Apr 24 Sep 5

ZTS lead: Reversed — TECH led by 2 AIQ points 30 sessions ago; ZTS now leads by 8.

Apr 24TECH leads above the line · ZTS leads belowSep 5
Today
ZTS +8
56 vs 64
7 sessions ago
ZTS +6
56 vs 62
30 sessions ago
TECH +2
59 vs 57
90 sessions ago
TECH +1
56 vs 55

The lead changed hands 2 times in this window, most recently on Aug 12 when TECH moved ahead of ZTS.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

TECHConflicted

4 bullish / 1 bearish / 1 neutral, conflicted

  • Golden Cross Active bullish, trend, long horizon (17.78%)
  • EMA Ribbon Expansion Bullish bullish, trend, medium horizon
  • 52-Week High Proximity bullish, risk, long horizon (0.2%)
ZTSConflicted

1 bullish / 1 bearish / 1 neutral, conflicted

  • Death Cross Active bearish, trend, long horizon (36.34%)
  • Bollinger Band Squeeze neutral, volatility, short horizon
  • MACD Bullish Crossover bullish, momentum, short horizon

ZTS leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

TECHNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.03%, AIQ 0 points).

ZTSNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.63%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1TECH closes the Value gap — currently 36 points behind, the largest single contributor to ZTS's edge.
  2. 2TECH generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover.
  3. 3ZTS's conflicting signal state resolves bearish — it currently carries 1 bullish and 1 bearish rules at once.
  4. 4A regime shift changes factor weighting — the composite weights Quality and Value at 30% each, so a rotation toward either would move the result most.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

ZTS leads on balance
MetricTECHZTS
Revenue growth (YoY)3.1%9.1%
EPS growth (YoY)6.1%16.2%
Gross margin65.8%70.9%
Operating margin20.7%37%
Return on equity (TTM)8.9%69.3%
Debt to equity0.142.93

Performance

TECH leads 5 of 6 windows
MetricTECHZTS
1 week (5 sessions)0.1%-2%
1 month (20 sessions)0.2%4.3%
3 months (63 sessions)39.3%-4.6%
6 months (126 sessions)34.4%-37.6%
Year to date23.2%-39.7%
1 year (252 sessions)35.8%-50.3%

Technicals

TECH has the stronger structure
MetricTECHZTS
RSI (14)51.358.9
ADX (14)52.910.9
Price vs 50-day0.8%0.3%
Price vs 200-day18.7%-26.4%
Volatility (1M, annualized)3.3%34.3%

Risk

TECH is the more resilient
MetricTECHZTS
Beta0.870.55
Sharpe ratio0.82-1.78
Sortino ratio1.13-1.79
Max drawdown-39.3%-53.1%
Current drawdown-0.1%-50.5%
Annualized volatility46.7%37.6%
Value at risk (95%)-3.8%-3.1%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, TECH or ZTS?

On the Algovestiq AIQ Score, ZTS is the stronger of the two as of Sep 6, 2026, scoring 64 against TECH's 56. The edge comes from value and quality. TECH is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is TECH or ZTS the better buy right now?

ZTS carries the stronger systematic profile as of Sep 6, 2026, and the comparison is rated Fragile — 4 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the lead has already changed hands inside the comparison window. Treat the lead as provisional.

Why does the AIQ Score favor ZTS over TECH?

The composite weights Quality at 30%, Value at 30%, Momentum at 25% and Risk Resilience at 15%. ZTS leads Value by 36 points; TECH leads Risk Resilience by 34 points; ZTS leads Quality by 4 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, TECH or ZTS?

Analyst price targets imply -11.5% upside for TECH and +27% for ZTS, so the Street currently favors ZTS. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, TECH or ZTS?

ZTS is the better-valued of the two on the peer-relative Value factor. ZTS on the peer-relative Value factor, by 36 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, TECH or ZTS?

ZTS on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, TECH or ZTS?

The two are level on Momentum. Momentum carries 25% of the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, TECH or ZTS?

TECH is the more resilient of the two, so the other name carries the higher downside risk. TECH on Risk Resilience, by 34 points. The Risk Resilience factor weights 15% of the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is TECH more profitable than ZTS?

ZTS leads on the comparable margin measures — gross margin 65.8% vs 70.9%; operating margin 20.7% vs 37%; ttm roe 8.9% vs 69.3%.

Is ZTS's lead over TECH getting stronger or weaker?

ZTS lead: Reversed — TECH led by 2 AIQ points 30 sessions ago; ZTS now leads by 8. This is measured from 120 daily comparison snapshots between 2026-04-24 and 2026-09-05. The lead has changed hands 2 times in that window, most recently on 2026-08-12, when TECH moved ahead of ZTS.

What would change the TECH vs ZTS verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: TECH closes the Value gap — currently 36 points behind, the largest single contributor to ZTS's edge; TECH generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover; ZTS's conflicting signal state resolves bearish — it currently carries 1 bullish and 1 bearish rules at once; a regime shift changes factor weighting — the composite weights Quality and Value at 30% each, so a rotation toward either would move the result most.

What do the current signals say about TECH and ZTS?

TECH: 4 bullish / 1 bearish / 1 neutral, conflicted. ZTS: 1 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on TECH is Golden Cross Active (bullish, long horizon). On ZTS it is Death Cross Active (bearish, long horizon).

Compare TECH and ZTS with others

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality (30%), Value (30%), Momentum (25%) and Risk (15%). Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.